Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome

Maria F. Gangale, Luca Miele, Antonio Lanzone, Francesca Sagnella, Daniela Martinez, Anna Tropea, Francesca Moro, Andrea Morciano, Andrea Ciardulli, Carola Palla, Maurizio Pompili, Consuelo Cefalo, Antonio Grieco, Rosanna Apa

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The objective of this study is to determine the ability of metformin treatment in reducing the prevalence of metabolic syndrome (MS) and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome (PCOS).
Original languageEnglish
Pages (from-to)520-527
Number of pages8
JournalClinical Endocrinology
Volume75
DOIs
Publication statusPublished - 2011

Keywords

  • Adult
  • Female
  • Humans
  • Hyperinsulinism
  • Hypoglycemic Agents
  • Liver
  • Metabolic Syndrome X
  • Metformin
  • Overweight
  • Polycystic Ovary Syndrome
  • Young Adult

Fingerprint

Dive into the research topics of 'Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome'. Together they form a unique fingerprint.

Cite this